. Early use of sotrovimab may protect against long COVID - IOPAC Press "Enter" to skip to content

Types of data requested to inform May 2025 COVID-19 vaccine antigen composition deliberations
- All WHO news
The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and antigenic evolution of...
New WHO guidance calls for urgent transformation of mental health policies
- All WHO news
The World Health Organization (WHO) today launched new guidance to help all countries reform and strengthen mental health policies and...
Decades of progress in reducing child deaths and stillbirths under threat, warns the United Nations
- All WHO news
The number of children dying globally before their fifth birthday declined to 4.8 million in 2023, while stillbirths declined modestly, still...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Early use of sotrovimab may protect against long COVID

By iopac on March 25, 2025

Only treatment within 10 days of COVID-19 diagnosis was associated with lower risk.

Published in COVID-19

iopac